
Treating breast cancer with MammoSite. resulted in a low risk of complications and was generally well tolerated, according to a University of Pittsburgh study. The study, presented at the 47th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Oct. 16 to 20, also evaluated cosmetic outcome of treatment with MammoSite and found that it was comparable to that of standard external beam radiation.

